In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Vassilev, L.T., Vu, B.T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., Fotouhi, N., Liu, E.A.(2004) Science 303: 844-848
- PubMed: 14704432 
- DOI: 10.1126/science.1092472
- Primary Citation of Related Structures:  
1RV1 - PubMed Abstract: 
MDM2 binds the p53 tumor suppressor protein with high affinity and negatively modulates its transcriptional activity and stability. Overexpression of MDM2, found in many human tumors, effectively impairs p53 function. Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy ...